In tumors removed from the animal on Day 16, thirteen days after cessation of the three-day drug treatment, we observed in 5 μm immuno-stained tumor sections that the expression of K-RAS, N-RAS and ERBB1 were all significantly reduced (Figure 4A). This evidence concerns the gene KRAS and neoplasm.